Bacteria expressing New Delhi metallo-β-lactamase-1 (NDM-1) can hydrolyze β-lactam
antibiotics (penicillins, cephalosporins, and carbapenems) and, thus, mediate multidrug …

The bacteria expressing New Delhi Metallo-β-lactamase-1 (NDM-1) can hydrolyze all β-
lactam antibiotics including carbapenems, causing multi-drug resistance. The worldwide …

Abstract Objectives Bacterial infections expressing New Delhi metallo-lactamase-1 (NDM-1)
pose an escalating global threat to healthcare systems. NDM-1 is an enzyme that renders β …

New Delhi metallo-β-lactamase-1 (NDM-1) can hydrolyze almost all antibiotics of the β-
lactam group, resulting in the generation of multidrug resistant bacteria. Besides its broad …

Superbugs producing New Delhi metallo-β-lactamase 1 (NDM-1) enzyme is a growing
crisis, that is adversely affecting the global health care system. NDM-1 empowers the …

New Delhi metallo-β-lactamase-1 (NDM-1), expressed in different Gram-negative bacteria,
is a versatile enzyme capable of hydrolyzing β-lactam rings containing antibiotics such as …

New Delhi metallo-β-lactmase-1 (NDM-1) has recently attracted extensive attention for its
biological activities to catalyze the hydrolysis of almost all of β-lactam antibiotics. To study …

The control of beta-lactam antibiotics released through the inhibition of the New Delhi
metallo-beta-lactamase 1 (NDM-1) has been identified as a potential target for the treatment …

Abstract Background New Delhi metallo-beta-lactamase-1 (NDM1) confers resistance to
several bacterial species against a broad range of beta-lactam antibiotics and turning them …

Bacterial resistance has become a worldwide concern after the emergence of metallo-β-
lactamases (MBLs). They represent one of the major mechanisms of bacterial resistance …